Stay current with insights from our analysts and industry updates. We also offer customised newsletters to keep your management, sales and marketing teams fully informed - contact us to find out more.
Stay current with insights from our analysts and industry updates. We also offer customised newsletters to keep your management, sales and marketing teams fully informed - contact us to find out more.
15-Sep-16 Biomedical manufacturing contributed just under SGD30 bn (USD41 bn) to Singapore's GDP in 2014. Of this, pharmaceuticals accounted for nearly SGD17 bn and medical technology about SGD11 bn. This sector employs over 18,000 workers, most of whom are highly skilled and technically qualified. [image: ZUU Online]
Read More
15-Sep-16 Non-government operators are being sought to redevelop and run five regional public hospitals across New South Wales in Australia. Under the partnership plan, the winning bidders would construct the hospitals then run them on behalf of the State Government. The Health Minister said partnering with non-government operators would allow the Government to provide bigger and faster redevelopments. [image: Chris Coleman / ABC News]
Read More
15-Sep-16 Prostate cancer is the second most common cancer among men worldwide. The projection data shows that the number of cases will double by 2020. "With the increased migration of rural population to the urban areas, changing lifestyles, increased awareness, and easy access to medical facility, more cases of prostate cancer are being picked up [in India]," said Dr Kumar, head of Urology at Safdarjang Hospital. [image: The Indian Express]
Read More
15-Sep-16 The Australian government has announced it will speed up the approval process for new medicines so that Australians can gain faster access to drugs. Currently, Australians are forced to wait up to two years longer than in other nations, but the new rules will allow drugs to be "fast-tracked" if approved by a regulator such as the USFDA. [image: News Corp Australia]
Read More
13-Sep-16 Intermountain Precision Genomics of the US and Singapore-based Asia Genomics are joining forces to deliver personalized medicine. First up is a test in Southeast Asia. Under the collaboration deal, the first for Intermountain outside the US, the firms are contracting to offer ICG100 testing. [image: Healthcare IT News]
Read MoreGGM is a research and advisory firm helping clients grow profitably in international markets.
We believe the only way to understand a market properly is on the ground. Intelligence from our in-country consultants gives you a competitive advantage in China, Asia, Latin America, the Middle East, Africa and other opportunity areas.
Our clients benefit from accurate data, reliable insights and strategic advice, giving them the confidence to make better business decisions and succeed in their global growth markets.
Successful track record in your sector since 1992
In-country research consultants in over 40 markets
Value for money - quality results at affordable rates
Work led by senior directors with >20 years experience
Proven frameworks for data analysis and strategy
Pragmatic advice based on accurate data and reliable insights
Find out more about our international market intelligence and strategy services
Get in touch to discuss your growth markets research and advisory needs:
Email: info@ggmkts.com